Get the Stockscreener App
10.07
2.72%
0.13
Electrocore Inc stock is traded at $10.07, with a volume of 45,168.
It is up +2.72% in the last 24 hours and up +66.02% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$9.94
Open:
$9.71
24h Volume:
45,168
Relative Volume:
0.40
Market Cap:
$91.42M
Revenue:
$34.90M
Net Income/Loss:
$-15.38M
P/E Ratio:
-5.5559
EPS:
-1.8125
Net Cash Flow:
$-6.87M
1W Performance:
+26.21%
1M Performance:
+66.02%
6M Performance:
+88.03%
1Y Performance:
+94.85%
1-Day Range:
$9.68
$10.39
1-Week Range:
$7.6771
$10.39
52-Week Range:
$4.41
$10.49
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
10.14 | 84.75M | 34.90M | -15.38M | -6.87M | -1.8125 |
ABT
Abbott Laboratories
|
111.56 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.07 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.30 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
52.19 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.32 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore (ECOR) investors report 9.9% stake and 1.55M-share warrant position - Stock Titan
More Money In The Bank For electroCore Insiders Who Divested US$746k - simplywall.st
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR) - The Globe and Mail
Analysts Set Expectations for electroCore Q3 Earnings - MarketBeat
Q3 EPS Estimates for electroCore Lifted by HC Wainwright - MarketBeat
electroCore (NASDAQ:ECOR) Issues Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
electroCore, Inc. (ECOR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
How Does electroCore Inc (ECOR) Measure Up After Q2 Earnings? EP - GuruFocus
ECOR Looks 25.1% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
Electrocore earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada
(ECOR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
electroCore Q2 Earnings Call Highlights - Yahoo Finance
electroCore, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - finance.yahoo.com
electroCore Q2 revenue jumps, but slightly misses estimates - TradingView
electroCore, Inc. Q2 2026: Revenue $9.45M, Net income (loss) $(3.06M) — 10-Q Summary - TradingView
[10-Q] electroCore, Inc. Quarterly Earnings Report - Stock Titan
ElectroCore, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
electroCore reports Q2 2026 sales $9.5M, narrows GAAP net loss to $3.1M and improves Adjusted EBITDA - TradingView
electroCore (NASDAQ: ECOR) lifts 2026 outlook after 28% Q2 growth - stocktitan.net
Electrocore, Inc. Increases Earnings Guidance for the Full Year 2026 - marketscreener.com
electroCore Q2 FY26 net loss narrows 17% to $3.1 million; net sales rise 28% to $9.5 million - Bitget
ECOR Looks 25.1% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
electroCore (ECOR) Advances 2.3% as Shares Hold Above Key SupportSmall Cap Breakouts - dars.gov.et
electroCore, Inc. expected to post a loss of 42 cents a shareEarnings Preview - TradingView
ECOR Looks 32.3% Undervalued on GF Value™ Amid Price-to-Sales Co - GuruFocus
electroCore to Participate in Upcoming Investor Conferences - The Manila Times
electroCore to present at two investor conferen... - Pluang
ECOR Q1 2026 Earnings: Narrower Loss Beats Estimates, but Shares Slip 3.26%Interim Report - dars.gov.et
electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026 - GlobeNewswire
electroCore to report Q2 2026 financial results on August 6 with a management webinar. - Pluang
electroCore (ECOR) Projected to Post Earnings on Wednesday - MarketBeat
electroCore, Inc. (ECOR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ECOR|electroCore, Inc.|Price:6.190|Chg%:-0.175 - TradingKey
electroCore Inc. (ECOR) Loses Ground: Support Levels in Focus After 2.75% DeclinePCR Moving Average - dars.gov.et
electroCore, Inc. (ECOR) Balance Sheet - TradingKey
electroCore, Inc. (ECOR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
electroCore, Inc. (ECOR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
electroCore, Inc. (ECOR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ECOR|electroCore, Inc.|Price:6.080|Chg%:-0.110 - TradingKey
TradingKey - TradingKey
electroCore, Inc. Revenue Breakdown – NASDAQ:ECOR - TradingView
electroCore, Inc. (ECOR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
electroCore (NASDAQ: ECOR) details 2026 virtual meeting and pay vote - Stock Titan
ElectroCore (ECOR) Gains 1.73% as Stock Approaches Key Resistance ZonePrice Gap Fill - dars.gov.et
electroCore (ECOR) Publishes New Review on Vagus Nerve Stimulati - GuruFocus
Outer Ear vs. Neck: Review Compares Two Vagus Nerve Paths - Stock Titan
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation - manilatimes.net
Why (ECOR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Price to sales forward of electroCore, Inc. – NASDAQ:ECOR - TradingView
Enterprise value to EBITDA forward of electroCore, Inc. – NASDAQ:ECOR - TradingView
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lev Joshua S. | CFO and Interim President |
May 28 '26 |
Sale |
9.00 |
6,667 |
60,003 |
84,889 |
0.81%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):